Peter Welch actually said...

"I would just urge us to try to look for some way where we address this patient choice issue, because I know a lot of my colleagues have that concern. I have that concern."

"the fact is that there is going to be a lot of resistance if there is an apprehension that a patient can't get the medication he or she needs."

"We have worked in a bipartisan manner on lowering drug costs over the last several years."

"I look forward to hearing from our witnesses, or our witness, on whether the current structure of how Part B drugs are reimbursed--can and should be modified to foster competition and to lower prices."